| Year |
Citation |
Score |
| 2019 |
Udayakumar D, Zhang Z, Dwivedi D, Xi Y, Wang T, Madhuranthakam A, Kapur P, Hajibeigi A, Joyce A, Yousuf Q, Fulkerson M, Leon ADd, Lewis M, Cadeddu J, Bagrodia A, et al. Abstract 1397: Quantitative MR imaging measures predict intratumoral molecular heterogeneity in clear cell renal cell carcinoma Cancer Research. 79: 1397-1397. DOI: 10.1158/1538-7445.Am2019-1397 |
0.307 |
|
| 2017 |
Gadhikar MA, Zhang J, Shen L, Rao X, Wang J, Zhao M, Kalu NN, Johnson FM, Byers LA, Heymach J, Hittelman WN, Udayakumar D, Pandita RK, Pandita TK, Pickering CR, et al. CDKN2A/p16 deletion in head and neck cancer cells is associated with Cdk2 activation, replication stress, and vulnerability to Chk1 inhibition. Cancer Research. PMID 29229598 DOI: 10.1158/0008-5472.Can-17-2802 |
0.377 |
|
| 2016 |
Udayakumar D, Pandita RK, Horikoshi N, Liu Y, Liu Q, Wong KK, Hunt CR, Gray NS, Minna JD, Pandita TK, Westover KD. Torin2 Suppresses Ionizing Radiation-Induced DNA Damage Repair. Radiation Research. PMID 27135971 DOI: 10.1667/Rr14373.1 |
0.49 |
|
| 2015 |
Udayakumar D, Dynan WS. Characterization of DNA binding and pairing activities associated with the native SFPQ·NONO DNA repair protein complex. Biochemical and Biophysical Research Communications. 463: 473-8. PMID 25998385 DOI: 10.1016/J.Bbrc.2015.05.024 |
0.636 |
|
| 2015 |
Udayakumar D, Horikoshi N, Mishra L, Hunt C, Pandita TK. Detecting ATM-dependent chromatin modification in DNA damage response. Methods in Molecular Biology (Clifton, N.J.). 1288: 317-36. PMID 25827888 DOI: 10.1007/978-1-4939-2474-5_18 |
0.511 |
|
| 2015 |
Pandita RK, Chow TT, Udayakumar D, Bain AL, Cubeddu L, Hunt CR, Shi W, Horikoshi N, Zhao Y, Wright WE, Khanna KK, Shay JW, Pandita TK. Single-strand DNA-binding protein SSB1 facilitates TERT recruitment to telomeres and maintains telomere G-overhangs. Cancer Research. 75: 858-69. PMID 25589350 DOI: 10.1158/0008-5472.Can-14-2289 |
0.463 |
|
| 2015 |
Udayakumar D, Pandita RK, Horikoshi N, Hunt CR, Liu Q, Wong K, Gray NS, Pandita TK, Westover KD. Abstract 2852: Torin2 suppresses ionizing radiation induced DNA damage repair Cancer Research. 75: 2852-2852. DOI: 10.1158/1538-7445.Am2015-2852 |
0.509 |
|
| 2015 |
Udayakumar D, Horikoshi N, Mishra L, Hunt C, Pandita TK. Detecting ATM-dependent chromatin modification in DNA damage response Methods in Molecular Biology. 1288: 317-336. DOI: 10.1007/978-1-4939-2474-5_18 |
0.306 |
|
| 2014 |
Xie T, Lim SM, Westover KD, Dodge ME, Ercan D, Ficarro SB, Udayakumar D, Gurbani D, Tae HS, Riddle SM, Sim T, Marto JA, Jänne PA, Crews CM, Gray NS. Pharmacological targeting of the pseudokinase Her3. Nature Chemical Biology. 10: 1006-12. PMID 25326665 DOI: 10.1038/Nchembio.1658 |
0.352 |
|
| 2014 |
Gupta A, Hunt CR, Hegde ML, Chakraborty S, Chakraborty S, Udayakumar D, Horikoshi N, Singh M, Ramnarain DB, Hittelman WN, Namjoshi S, Asaithamby A, Hazra TK, Ludwig T, Pandita RK, et al. MOF phosphorylation by ATM regulates 53BP1-mediated double-strand break repair pathway choice. Cell Reports. 8: 177-89. PMID 24953651 DOI: 10.1016/J.Celrep.2014.05.044 |
0.455 |
|
| 2013 |
Kazerounian S, Gerald D, Huang M, Chin YR, Udayakumar D, Zheng N, O'Donnell RK, Perruzzi C, Mangiante L, Pourat J, Phung TL, Bravo-Nuevo A, Shechter S, McNamara S, Duhadaway JB, et al. RhoB differentially controls Akt function in tumor cells and stromal endothelial cells during breast tumorigenesis. Cancer Research. 73: 50-61. PMID 23135917 DOI: 10.1158/0008-5472.Can-11-3055 |
0.325 |
|
| 2013 |
Kumar R, Njauw C, Ji Z, Miao B, Taylor M, Rajadurai A, Udayakumar D, Tsao H. Abstract 776: Functional analysis of BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) in melanoma. Cancer Research. 73: 776-776. DOI: 10.1158/1538-7445.Am2013-776 |
0.339 |
|
| 2011 |
Udayakumar D, Zhang G, Ji Z, Njauw CN, Mroz P, Tsao H. Epha2 is a critical oncogene in melanoma Oncogene. 30: 4921-4929. PMID 21666714 DOI: 10.1038/Onc.2011.210 |
0.349 |
|
| 2010 |
Boni A, Cogdill AP, Dang P, Udayakumar D, Njauw CN, Sloss CM, Ferrone CR, Flaherty KT, Lawrence DP, Fisher DE, Tsao H, Wargo JA. Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function. Cancer Research. 70: 5213-9. PMID 20551059 DOI: 10.1158/0008-5472.Can-10-0118 |
0.346 |
|
| 2010 |
Boni A, Cogdill A, Udayakumar D, Njauw CJ, Ferrone C, Lawrence D, Flaherty K, Fisher D, Tsao H, Wargo JA. Abstract 1970: Inhibition of BRAF-V600E increases melanocyte antigen expression and antigen-specific recognition in melanoma without altering T cell function Cancer Research. 70: 1970-1970. DOI: 10.1158/1538-7445.Am10-1970 |
0.315 |
|
| 2009 |
Udayakumar D, Zhang G, Njauw CJ, Ji Z, Mroz P, Tsao H. Abstract A33: EphA2 Receptor: Evidence for a proto-oncogenic role in melanoma Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-A33 |
0.362 |
|
| 2008 |
Xue Q, Hopkins B, Perruzzi C, Udayakumar D, Sherris D, Benjamin LE. Palomid 529, a novel small-molecule drug, is a TORC1/TORC2 inhibitor that reduces tumor growth, tumor angiogenesis, and vascular permeability. Cancer Research. 68: 9551-7. PMID 19010932 DOI: 10.1158/0008-5472.Can-08-2058 |
0.315 |
|
| 2005 |
Bladen CL, Udayakumar D, Takeda Y, Dynan WS. Identification of the polypyrimidine tract binding protein-associated splicing factor.p54(nrb) complex as a candidate DNA double-strand break rejoining factor. The Journal of Biological Chemistry. 280: 5205-10. PMID 15590677 DOI: 10.1074/Jbc.M412758200 |
0.599 |
|
| 2004 |
Lee KJ, Jovanovic M, Udayakumar D, Bladen CL, Dynan WS. Identification of DNA-PKcs phosphorylation sites in XRCC4 and effects of mutations at these sites on DNA end joining in a cell-free system. Dna Repair. 3: 267-76. PMID 15177042 DOI: 10.1016/J.Dnarep.2003.11.005 |
0.638 |
|
| 2003 |
Udayakumar D, Bladen CL, Hudson FZ, Dynan WS. Distinct pathways of nonhomologous end joining that are differentially regulated by DNA-dependent protein kinase-mediated phosphorylation. The Journal of Biological Chemistry. 278: 41631-5. PMID 12917393 DOI: 10.1074/Jbc.M306470200 |
0.651 |
|
| Show low-probability matches. |